Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial

Gastroenterology
Geert R D'HaensPaul Rutgeerts

Abstract

More than 80% of Crohn's disease (CD) patients undergoing resection suffer recurrence of their disease. Therapy with aminosalicylates, antimetabolites, or antibiotics leads to a modest reduction in the incidence of recurrence. We sought to examine whether metronidazole for 3 months together with azathioprine (AZA) for 12 months is superior to metronidazole alone to reduce recurrence of postoperative CD in "high-risk" patients. CD patients undergoing curative ileocecal resection with >or=1 risk factor for recurrence received metronidazole (3 months) and AZA/placebo (12 months). The primary end point was the proportion of patients with significant endoscopic recurrence 3 and 12 months after surgery. Secondary end points included clinical recurrence, safety, and tolerability of treatment. Eighty-one patients were randomized; 19 discontinued the study early. Significant endoscopic recurrence was observed in 14 of 32 (43.7%) patients in the AZA group and in 20 of 29 (69.0%) patients in the placebo group at 12 months postsurgery (P = .048). Intention-to-treat analysis revealed endoscopic recurrence in 22 of 40 (55%) in the AZA group and 32 of 41 (78%) in the placebo group at month 12 (P = .035). At month 12, 7 of 32 patients had no e...Continue Reading

Citations

Sep 30, 2010·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Taiwo A LawalMarc A Levitt
May 10, 2011·Drug Design, Development and Therapy·John K TriantafillidisFilippos Georgopoulos
Jun 3, 2010·World Journal of Gastroenterology : WJG·Peter Laszlo Lakatos, Lajos S Kiss
Nov 24, 2011·World Journal of Gastroenterology : WJG·Peter Laszlo Lakatos, Lajos S Kiss
Sep 13, 2012·World Journal of Gastroenterology : WJG·Mariam AguasPilar Nos
Feb 23, 2013·World Journal of Gastroenterology : WJG·Maria Lia Scribano, Cosimo Prantera
Mar 8, 2013·World Journal of Gastroenterology : WJG·Pascal FreiGerhard Rogler
Dec 1, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Jonathan Landy, Alisa Hart
Nov 19, 2013·Journal of Comparative Effectiveness Research·Sara RennaMario Cottone
Sep 16, 2014·The Proceedings of the Nutrition Society·A L Hart, P Hendy
Jan 14, 2016·Scandinavian Journal of Gastroenterology·Maria Teresa Herranz BachillerRamon Atienza Sanchez
Nov 25, 2014·Expert Opinion on Pharmacotherapy·Andrea AffrontiMario Cottone
May 1, 2015·Journal of Crohn's & Colitis·Marc FerranteUNKNOWN International Organization for Study of Inflammatory Bowel Diseases
Dec 10, 2014·The American Journal of Gastroenterology·Charles N Bernstein
Jul 13, 2016·Journal of Crohn's & Colitis·Matti WatermanYehuda Chowers
Sep 30, 2016·Expert Review of Gastroenterology & Hepatology·Vu NguyenDario Sorrentino
Mar 8, 2017·Journal of Pediatric Gastroenterology and Nutrition·Jorge Amil-DiasUNKNOWN IBD Working Group of ESPGHAN (IBD Porto Group)
Dec 4, 2014·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·H Sales-CamposC R B Cardoso
Dec 9, 2010·Arquivos De Gastroenterologia·UNKNOWN Brazilian Study Group of Inflammatory Bowel Diseases
Mar 4, 2017·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Paolo GionchettiUNKNOWN Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Feb 1, 2010·Clinical Journal of Gastroenterology·Yuji FunayamaIwao Sasaki
Jul 2, 2009·The American Journal of Gastroenterology·Laurent Peyrin-BirouletJean-Frédéric Colombel
Aug 2, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Clotilde BaudryMatthieu Allez
Jan 7, 2015·Pharmacology & Therapeutics·Giovanni CammarotaDiego Currò
Dec 18, 2013·Journal of Crohn's & Colitis·Fernando MagroGuilherme Macedo
Apr 13, 2017·Journal of Crohn's & Colitis·Antonio López-SanrománUNKNOWN Spanish GETECCU group [APPRECIA study]
Dec 15, 2016·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Lillias Holmes MaguireLiliana Bordeianou
Aug 19, 2015·United European Gastroenterology Journal·Thomas KlagJan Wehkamp
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Sandro ArdizzoneGabriele Bianchi Porro
Mar 2, 2017·Journal of Pediatric Gastroenterology and Nutrition·Kristyna ZarubovaJiri Bronsky
Jun 12, 2014·Inflammatory Bowel Diseases·Emily K WrightMichael A Kamm
Oct 21, 2016·Inflammatory Bowel Diseases·Christian MottetPierre Michetti
Jan 27, 2009·Inflammatory Bowel Diseases·Frans van der HeideGerard Dijkstra
Mar 27, 2009·Inflammatory Bowel Diseases·Miguel Regueiro
Mar 5, 2015·Inflammatory Bowel Diseases·Jean-Paul MottaJohn L Wallace
Mar 5, 2016·Inflammatory Bowel Diseases·Sanchit BhasinCharles N Bernstein
Jun 16, 2011·Inflammatory Bowel Diseases·T D WaltersR S McLeod
May 23, 2009·Inflammatory Bowel Diseases·Glen A Doherty, Adam S Cheifetz
Apr 28, 2012·Inflammatory Bowel Diseases·Peter De CruzGreg Moore
Apr 22, 2015·Inflammatory Bowel Diseases·Emily K Wright, Michael A Kamm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.